glp 1 agonists and pancreatitis Reconciling GLP-1s Clinical Focus on GLP-1 Agonists

Its the way we treat heart failure, HIV, tuberculosis, blood pressure, and many other diseases in medicine

doi: 10.2337/dc10-1677

13 In this review, we summarise the evidence related to the effects of GLP-1 RAs on these outcomes ( Figure 1 ), which may shed light on the potential of these agents to be used in the clinical care of HF patients and investigated in large clinical trials to evaluate clinical outcomes

2012 Mar;153(3):1538-47

This is concerning because building and maintaining lean muscle mass is crucial for not only weight loss but overall health and longevity

The cardiovascular protection begins shortly after starting treatment and persists long-term